The safety and tolerability profile of bilastine for chronic urticaria in children

Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties

(2019) Hideyuki Kawauchi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

(2018) T. Zuberbier et al.   ALLERGY

Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria

(2018) Ander Sologuren et al.   ALLERGY AND ASTHMA PROCEEDINGS

The role and relevance of mast cells in urticaria

(2018) Martin K. Church et al.   IMMUNOLOGICAL REVIEWS

Chronic urticaria - What does the new guideline tell us?

(2018) Marcus Maurer et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor

(2018) Reggie Bosma et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Comparative study of the effect of bilastine and cetirizine on cognitive functions at ground level and at an altitude of 4,000 m simulated in hypobaric chamber: a randomized, double-blind, placebo-controlled, cross-over study

(2018) Ákos Reményi et al.   Expert Opinion On Drug Safety

Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population

(2018) Valvanera Vozmediano et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design

(2017) Valvanera Vozmediano et al.   PHARMACEUTICAL RESEARCH

The clinical pharmacology of non-sedating antihistamines

(2017) Kazuhiko Yanai et al.   PHARMACOLOGY & THERAPEUTICS

Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria

(2017) Elena Netchiporouk et al.   JAMA Dermatology

Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study

(2017) Michihiro Hide et al.   ALLERGOLOGY INTERNATIONAL

Schooltime subjective sleepiness and performance in Italian primary school children

(2016) Mariangela Cerasuolo et al.   CHRONOBIOLOGY INTERNATIONAL

Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers

(2016) Rosa Antonijoan et al.   CURRENT MEDICAL RESEARCH AND OPINION

One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases

(2016) Akiko Yagami et al.   JOURNAL OF DERMATOLOGY

Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases

(2016) Zoltán Novák et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

(2016) De Yun Wang et al.   Therapeutics and Clinical Risk Management

Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years

(2015) Paul Potter et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Bilastinevs.hydroxyzine: occupation of brain histamine H1-receptors evaluated by positron emission tomography in healthy volunteers

(2014) Magí Farré et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Can On-demand Non-sedating Antihistamines Improve Urticaria Symptoms? A Double-blind, Randomized, Single-dose Study

(2013) K Weller et al.   ACTA DERMATO-VENEREOLOGICA

Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency

(2013) Kenneth C. Lasseter et al.   CLINICAL DRUG INVESTIGATION

An overview of bilastine metabolism during preclinical investigations

(2012) María Luisa Lucero et al.   DRUG AND CHEMICAL TOXICOLOGY

Safety and efficacy of bilastine: a new H1-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria

(2011) Martin K Church   Expert Opinion On Drug Safety

Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease

(2011) A.N. Pampura et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Lack of Significant Effect of Bilastine Administered at Therapeutic and Supratherapeutic Doses and Concomitantly With Ketoconazole on Ventricular Repolarization: Results of a Thorough QT Study (TQTS) With QT-Concentration Analysis

(2011) Benoît Tyl et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences

(2011) George N. Konstantinou et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Epidemiology of urticaria: a representative cross-sectional population survey

(2010) T. Zuberbier et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers

(2010) Silke Conen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The influence of sleep quality, sleep duration and sleepiness on school performance in children and adolescents: A meta-analytic review

(2010) Julia F. Dewald et al.   SLEEP MEDICINE REVIEWS

How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine dailyvsPRN and quality of life

(2009) J.-J. Grob et al.   ALLERGY

Comparison of the efficacy and safety of bilastine 20 mgvslevocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study

(2009) T. Zuberbier et al.   ALLERGY

Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine

(2009) Nerea Jauregizar et al.   CLINICAL PHARMACOKINETICS